XORTX Therapeutics Secures Orphan Drug Designation for Oxypurinol to Treat Autosomal Dominant Polycystic Kidney Disease
XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company that aims to create new therapies to treat progressive kidney disease, is excited to announce that they have received Orphan Drug ...
FDA Grants Fast Track Designation to Bayer’s Asundexian for Stroke Prevention in Atrial Fibrillation Patients
Bayer has officially announced that the U.S. FDA has awarded Fast Track Designation to their investigational drug known as asundexian (BAY2433334). This designation recognizes its potential use as a t ...
Total Incidence Cases of Acute Respiratory Distress Syndrome (ARDS) in U.S. 2022 – 2032
[vc_row][vc_column][vc_custom_heading text="Total Incidence Cases of Acute Respiratory Distress Syndrome (ARDS) in U.S. 2022 – 2032" font_container="tag:h2|text_align:center" use_theme_fonts="yes"][/v ...